<SEC-DOCUMENT>0001493152-26-009983-index.html : 20260313
<SEC-HEADER>0001493152-26-009983.hdr.sgml : 20260313
<ACCEPTANCE-DATETIME>20260313080003
ACCESSION NUMBER:		0001493152-26-009983
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260311
FILED AS OF DATE:		20260313
DATE AS OF CHANGE:		20260313

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Parsons James T.
		CENTRAL INDEX KEY:			0001759855
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38512
		FILM NUMBER:		26750106

	MAIL ADDRESS:	
		STREET 1:		C/O DIAMEDICA THERAPEUTICS INC.
		STREET 2:		301 CARLSON PARKWAY, SUITE 210
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55305

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		804, 322 - 11 AVENUE SW
		CITY:			CALGARY
		PROVINCE COUNTRY:   	A0
		BUSINESS PHONE:		4036707377

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		804, 322 - 11 AVENUE SW
		CITY:			CALGARY
		PROVINCE COUNTRY:   	A0
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>